Radiation clonogenic assays showed that DDX42 knockdown increased radio‐sensitivity in HCC cells (Figure 5O), and CCK‐8 assay showed that DDX42 knockdown significantly enhanced the efficacy of sorafenib (Figure 5P). The gene discussed is DDX42; the disease is hepatocellular carcinoma.